August 2008 Editor's Picks: Products from OYSTAR Manesty and Hawk - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

August 2008 Editor's Picks: Products from OYSTAR Manesty and Hawk


Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

product OYSTAR Manesty
Tablet press produces scalable results

The fully automated, single-station “Flexitab” tablet press from OYSTAR Manesty (Fairfield, NJ) is designed to produce results similar to those of a rotary press. The device’s two punches are each controlled by one pneumatic and one hydraulic cylinder, which help the unit achieve the same punch travel velocity and force as a rotary press. Scientists can “optimize a formulation with only a small amount of material,” according to Nic Michel, vice-president of OYSTAR USA’s process division.

In addition, the Flexitab machine produces single layer, bilayer, and trilayer tablets. Three hoppers are mounted on the press’s die table. Each hopper has a pneumatically driven slide-feeder mechanism that automatically fills each tablet layer and compresses between each layer.

Michel adds that operators can set the unit’s dwell time and punch displacement and store various compression profiles in the device’s memory.



productHawk
Detectors incorporate adjustable sensitivity

Hawk (Melbourne, Australia) has added microwave-beam blockage-detecting systems to its “Gladiator” series of level-detection switches. The units use microwave energy, which penetrates plastic, glass, ultrahigh-molecular-weight polyethylene, PTFE, firebrick, and ceramic materials. The devices do not suffer from false tripping or fail to respond like traditional tilt switches, according to Hawk.

The system’s sender transmits rapid bursts of microwave energy to a corresponding receiver, which can be mounted as far as 100 m away. The presence or absence of the signal at the receiver switches a relay for indication or control purposes. The detector’s sensitivity is adjustable, and operators can allow the system to tolerate buildup or changes in material properties.

Systems are available in remote and stand-alone configurations and are not intrusive to manufacturing processes. The product is suitable for blocked-chute detection in wet-, dry-, and bulk-material conveying and transfer systems.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Equipment and Processing Report,
Click here